Trisoxazole Macrolides Potentiate the Microtubule Assembly and Antimitotic Activities of Taxanes
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.202522954 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Shohei Ebihara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Bioagricultural Sciences, Nagoya University Furo-Cho Chikusa, Nagoya, Japan. Hauptthemen laut MEDLINE: Macrolides, Microtubules, Oxazoles, Antimitotic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Mycalolides are marine‐derived trisoxazole macrolides that exhibit potent actin‐depolymerizing activity and inhibit the proliferation, migration, and invasion of various cancer cells. The C25–C35 side‐chain moiety of mycalolides is important for their actin‐binding properties; however, the biological function of the C1–C24 trisoxazole macrolactone moiety remains largely unexplored. In this study, using a photoaffinity biotin probe, we identified tubulin as a new, actin‐independent target of mycalolide C (MyC). Ultracentrifugation, fluorescence‐based tubulin polymerization assays, and transmission electron microscopy of negatively stained microtubules (MTs) demonstrated that MyC and trisoxazole macrolactones exert potent synergistic effects on paclitaxel‐induced MT assembly and stabilization. These compounds enhanced the antiproliferative activity of paclitaxel by 4.2‐ to 6.7‐fold in HCT‐116 human colon cancer cells but showed little synergy in 3T3‐L1 murine fibroblast. Molecular modeling studies suggest that MyC stabilizes the protein–protein interactions between α/β‐tubulin heterodimers. Given that the C1–C24 trisoxazole macrolactone moiety and its analogues exhibit little cytotoxicity, our findings may contribute to the development of new lead compounds for MT inhibitors with reduced side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Bioagricultural Sciences, Nagoya University Furo-Cho Chikusa, Nagoya, Japan.
- Graduate School of Pharmaceutical Sciences, Nagoya University Furo-Cho Chikusa, Nagoya, Japan.
- Cellular and Structural Physiology Institute (CeSPI), Nagoya University Furo-Cho Chikusa, Nagoya, Japan.
- Institute For Glyco-core Research (iGCORE), Nagoya University Furo-Cho Chikusa, Nagoya, Japan.
- Center For One Medicine Innovative Translational Research (COMIT), Nagoya University Furo-Cho, Chikusa, Nagoya, Japan.
- Institute of Quantum Chemistry Innovation, Institutes of Innovation for Future Society, Nagoya University Furo-Cho Chikusa, Nagoya, Japan.
ORCID-Profile: Masaki Kita
Förderung
- JSPS
- Japan Society for the Promotion of Science
Zitieren
APA
Ebihara, S., Takaiso, R., Kawaguchi, S., Oshima, A., & Kita, M. (2026). Trisoxazole Macrolides Potentiate the Microtubule Assembly and Antimitotic Activities of Taxanes. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202522954
Vancouver
Ebihara S, Takaiso R, Kawaguchi S, Oshima A, Kita M. Trisoxazole Macrolides Potentiate the Microtubule Assembly and Antimitotic Activities of Taxanes. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.202522954
BibTeX
@article{Ebihara2026,
author = {Ebihara, Shohei and Takaiso, Rio and Kawaguchi, Shota and Oshima, Atsunori and Kita, Masaki},
title = {Trisoxazole Macrolides Potentiate the Microtubule Assembly and Antimitotic Activities of Taxanes},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.202522954}
}
EUVIMED